Insights

Strong Industry Position EMBL-EBI is a leading organization in bioinformatics with a substantial revenue estimated between 500 million to one billion dollars, indicating significant financial stability and market influence that could facilitate large-scale collaborations or technology adoption.

Dedicated Innovation The company's recent launches of high-impact platforms such as the COVID-19 Data Portal, Global Biodiversity Portal, and species-specific databases highlight a focus on cutting-edge research tools, presenting opportunities for partners offering advanced data management and analytical solutions.

Technological Engagement Utilizing a modern tech stack that includes Hadoop, GitHub, and Red Hat, EMBL-EBI demonstrates a strong commitment to scalable and secure technology solutions, which may benefit from advanced cloud, security, or collaboration tools to optimize their infrastructure.

Collaborative Network Partnerships with organizations like DeepMind and participation in global biodiversity projects suggest that EMBL-EBI values strategic collaborations, indicating potential for expansion into joint research initiatives or data-sharing platforms.

Market Focus With an extensive portfolio of biological and genomic data services aimed at research, healthcare, agriculture, and biodiversity, there are diverse sector opportunities for selling specialized software, data analytics tools, or consulting services tailored to these fields.

Similar companies to European Bioinformatics Institute | EMBL-EBI

European Bioinformatics Institute | EMBL-EBI Tech Stack

European Bioinformatics Institute | EMBL-EBI uses 8 technology products and services including SaltStack, Apache Maven, GitHub, and more. Explore European Bioinformatics Institute | EMBL-EBI's tech stack below.

  • SaltStack
    Build Automation
  • Apache Maven
    Build Automation
  • GitHub
    Communication And Collaboration
  • Apple iCloud Mail
    Email
  • Material-UI
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Red Hat
    Operating Systems
  • Hadoop
    Programming Languages

Media & News

European Bioinformatics Institute | EMBL-EBI's Email Address Formats

European Bioinformatics Institute | EMBL-EBI uses at least 1 format(s):
European Bioinformatics Institute | EMBL-EBI Email FormatsExamplePercentage
First.Last@ebi.ac.ukJohn.Doe@ebi.ac.uk
78%
First@ebi.ac.ukJohn@ebi.ac.uk
9%
Last@ebi.ac.ukDoe@ebi.ac.uk
8%
FLast@ebi.ac.ukJDoe@ebi.ac.uk
5%

Frequently Asked Questions

What is European Bioinformatics Institute | EMBL-EBI's phone number?

Minus sign iconPlus sign icon
You can contact European Bioinformatics Institute | EMBL-EBI's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is European Bioinformatics Institute | EMBL-EBI's stock symbol?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI is a publicly traded company; the company's stock symbol is TREB-UN.

What is European Bioinformatics Institute | EMBL-EBI's official website and social media links?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI's official website is ebi.ac.uk and has social profiles on LinkedIn.

What is European Bioinformatics Institute | EMBL-EBI's SIC code NAICS code?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI's SIC code is 7299 - Miscellaneous Personal Services, Not Elsewhere Classified NAICS code is 5112 - Software Publishers.

How many employees does European Bioinformatics Institute | EMBL-EBI have currently?

Minus sign iconPlus sign icon
As of December 2025, European Bioinformatics Institute | EMBL-EBI has approximately 820 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: C. O.President: S. S.Head Of Research: J. S. R.. Explore European Bioinformatics Institute | EMBL-EBI's employee directory with LeadIQ.

What industry does European Bioinformatics Institute | EMBL-EBI belong to?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI operates in the Software Development industry.

What technology does European Bioinformatics Institute | EMBL-EBI use?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI's tech stack includes SaltStackApache MavenGitHubApple iCloud MailMaterial-UIModernizrRed HatHadoop.

What is European Bioinformatics Institute | EMBL-EBI's email format?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI's email format typically follows the pattern of First.Last@ebi.ac.uk. Find more European Bioinformatics Institute | EMBL-EBI email formats with LeadIQ.

When was European Bioinformatics Institute | EMBL-EBI founded?

Minus sign iconPlus sign icon
European Bioinformatics Institute | EMBL-EBI was founded in 1994.

European Bioinformatics Institute | EMBL-EBI

Software DevelopmentEngland, United Kingdom501-1000 Employees

Working at EMBL-EBI gives you the opportunity to focus your energy and skills on something that really matters: using technology to contribute to discoveries that benefit humankind. We empower researchers everywhere to realise the potential of ‘big data’ in biology, and build sophisticated tools for exploring life at the atomic level.

Section iconCompany Overview

Phone number
Website
ebi.ac.uk
SIC Code
7299 - Miscellaneous Personal Services, Not Elsewhere Classified
Stock Symbol
TREB-UN
NAICS Code
5112 - Software Publishers
Founded
1994
Employees
501-1000

Section iconFunding & Financials

  • $500M$1B

    European Bioinformatics Institute | EMBL-EBI's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    European Bioinformatics Institute | EMBL-EBI's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.